SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely targets tumors, today announced an ...
Cartography Biosciences is putting its name on the map, exiting stealth mode with $57 million for an antigen atlas designed to direct scientists to more precise and effective immunotherapies.
Digital maps today are often high fidelity works of art, with a precision, detail, and range of color not seen in other formats. Modern digital cartography also boasts a range of interactive features.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, an immuno-oncology company creating biologic therapies against novel targets guided by the first-ever comprehensive antigen atlas ...